Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for Petrobras Brasileiro A Dynamic Market Landscape

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Energy Company Market Capitalization
0
SHARES
18
VIEWS
Share on FacebookShare on Twitter

On March 12, 2024, analyst Bruno Amorim from Goldman Sachs reiterated a Buy rating on Petrobras Brasileiro (NYSE:PBR) while adjusting the price target from $19.7 to $17.6. This update follows a previous upgrade from Neutral to Buy and a price target increase from $13 to $18.1. Conversely, B of A Securities has set a new price target of $16.00 for Petrobras Brasileiro, anticipating a potential 7.45% upside in the next 12 months. The fluctuating analyst ratings and recommendations for Petrobras Brasileiro underscore the ever-changing landscape of stock analysis and market conditions.

Petrobras (PBR) Stock Sees Slight Increase, But Long-Term Growth Uncertain

On March 12, 2024, Petrobras (PBR) saw a slight increase in its stock performance. The stock opened at $14.83, which was $0.27 higher than its previous close. Throughout the trading day, PBR shares increased by $0.25, resulting in a 1.72% rise in its price. Despite this positive movement, PBR is currently trading in the middle of its 52-week range and below its 200-day simple moving average. This indicates that the stock may not be experiencing significant upward momentum in the long term. Investors may want to consider these factors when evaluating PBR as a potential investment. While the short-term price increase is a positive sign, the overall trend of the stock suggests that it may not be experiencing strong growth. It is important for investors to conduct thorough research and analysis before making any investment decisions. By considering the price momentum and overall performance of PBR, investors can make informed choices about whether or not to include this stock in their portfolio.

PBR Stock Performance on March 12, 2024: Revenue, Net Income, and EPS Decline

On March 12, 2024, investors were closely watching the performance of PBR stock after the company released its financial results. According to data from CNN Money, PBR reported a total revenue of $102.50 billion for the past year, with $27.09 billion in revenue for the fourth quarter. Similarly, PBR’s net income for the past year was reported at $24.95 billion, with $6.26 billion in net income for the fourth quarter. Earnings per share (EPS) for PBR were reported at $3.83 for the past year and $0.97 for the fourth quarter. Overall, PBR’s financial performance on March 12, 2024, showed a decline in total revenue, net income, and earnings per share compared to the previous year. However, the company managed to maintain its performance from the previous quarter, which may have been seen as a positive sign by investors. Investors and analysts will continue to monitor PBR’s financial performance in the coming quarters to see if the company can reverse the downward trend in revenue, net income, and earnings per share. The stock performance on March 12, 2024, may have reflected investor sentiment towards PBR’s financial results and future outlook.

Tags: PBR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Mining technology

MicroCloud Hologram Shares Surge After Trading Resumes

Biotechnology Stock Exchange

Analysts Bullish on Alpine Immune Sciences Price Targets and Ratings Upgraded

Finance_Commercial (2)

Reminder WT Offshore ExDividend Date Approaching

Recommended

K+S Stock

U.S. Sanctions Relief for Belarus Sends K+S Shares Tumbling

4 days ago
Finance_ Charts for stock trading

AMark Precious Metals Inc to Acquire Prominent Asian Precious Metals Dealer LPM Group Limited

2 years ago
European Lithium Stock

European Lithium Shares Reflect Divergent Investor Sentiment

3 months ago
RLI stock news

Chicago Partners Investment Group LLC’s Surprising Reduction in Stake Raises Questions for Qurate Retail

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

Ocugen Shares Tumble Despite Positive Clinical Trial Results

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

Trending

Lexaria Bioscience Stock
Healthcare

Lexaria Bioscience Targets Multi-Billion Dollar Market with Side-Effect Solution

by Rodolfo Hanigan
March 25, 2026
0

Lexaria Bioscience is positioning its proprietary DehydraTECH technology as a potential solution to a critical problem plaguing...

Watsco Stock

Watsco’s Dividend Hike Contrasts with Operational Headwinds

March 25, 2026
Pinduoduo Stock

Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant

March 25, 2026
XPeng Stock

XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch

March 25, 2026
Oracle Stock

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Lexaria Bioscience Targets Multi-Billion Dollar Market with Side-Effect Solution
  • Watsco’s Dividend Hike Contrasts with Operational Headwinds
  • Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com